Global Phase II/III CRO Benchmarking Report 2022: Analysis of CRO Selection and Share Performance Data for 31 Providers on 21 Key Attributes - ResearchAndMarkets.com
2023-01-16
DUBLIN--(BUSINESS WIRE)--The "Phase II/III CRO Benchmarking (14th Ed.)" report has been added to ResearchAndMarkets.com's offering.
Although the landscape for outsourcing clinical research changes with each passing year, the goal of our CRO benchmarking reports remains the same: to help sponsors make educated decisions and to help CROs understand how they stack up against competitors on brand positioning and performance metrics.
229 experienced decision-makers that select and work with Phase II/III service providers contributed to this year's report, representing 776 encounters between outsourcers and CROs. We analyze a variety of factors around CRO selection and share performance data for 31 providers on 21 key attributes, including budget factors, delivery factors, staff characteristics, and services.
Knowing which attributes are important for success and understanding the strength of various brands is one part of the puzzle - but how well are CROs actually performing against expectations?
The bulk of this report on CRO performance is designed to help sponsors determine which providers will deliver effectively and for CROs to benchmark their performance against the industry's quality standards. For sponsors, we are confident that this report will help you to make the right decision for your clinical development program.
And for CROs, with these insights, you can design marketing materials that effectively promote your company's service offerings.
What you will learn:
Sponsors:
Learn which service providers your company should keep in mind for your clinical development programs by identifying how individual CROs have performed for your peers
Better understand CRO customer loyalty based on overall customer satisfaction, willingness to recommend, and likelihood to use again
Discover which Phase II/III-specific attributes motivate outsourcing selection, and evaluate verbatim responses from recent customers on CRO performance
CROs:
Understand how recent customers have rated your company's performance across 21 key attributes
Learn how to improve your marketing messaging by focusing on the areas in which customers say you excel compared to the competition
Read verbatim customer rationale for their satisfaction level with your company's performance
Find out which factors affect sponsor outsourcing preferences, and which factors are gaining in importance for future outsourcing
Major Topics:
Service Provider Selection Process
Service Provider Perceptions and Interactions
Service Provider Performance and Loyalty
Company Service Quality Profiles
Key Topics Covered:
Copyright and Usage Guidelines
How to Use this Report
Analysis Note: Outsourcing Requirement
Introduction
Methodology
Demographics
Number of Ratings per Company
Major Sections
Service Provider Selection Process
Primary Section Takeaways
Preferred Provider Agreements
Selection Attributes
Use of Outside Consultants for CRO Identification and Selection
Service Provider Perceptions and Interactions
Primary Section Takeaways
Phase II/III Leadership, Familiarity, and Reported Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Cost Experience among Users
Summary Table
Service Provider Performance and Loyalty
Primary Section Takeaways
Budget Factors
Delivery Factors
Staff Characteristics
Services
A Note on Harvey Ball Calculations
Performance Across Service Providers
Budget Factors
Delivery Factors
Staff Characteristics
Services
Customer Loyalty: 2022
Customer Loyalty: 3-Year Rolling Average
Company Service Quality Profiles
Study Data
Phase II/III Leaders, Unprompted
Other Responses
Phase II/III Leaders, Prompted
Service Provider Familiarity
Service Provider Familiarity - Additional Providers
Service Provider Reported Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Use of Outside Consultants for CRO Identification and Selection
Service Provider Drill-downs
Advanced Clinical
Clinipace
Clintec
CTI Clinical Trial & Consulting
DCRI-Duke
Eurofins (including bioskin)
Frontage
George Clinical
ICON (including PRA)
Innovaderm
IQVIA
Novotech
Ora
PharPoint
PPD
Precision for Medicine
PSI
QPS
Rho
Syneos Health (including Synteract)
UBC
Worldwide Clinical Trials
Demographics
Company Size
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
About the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/hvbdv9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。